Endpoints in trials for clinical liver transplantation

Kenneth Washburn

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


One balanced approach for assessing newer immunosuppressive therapies might be to use composite endpoints, combining conventional endpoints (graft loss, death, acute rejection) with contemporary endpoints (renal function, histological indices). A re-assessment of contemporary control groups is warranted.

Original languageEnglish (US)
Pages (from-to)252-256
Number of pages5
JournalCurrent Opinion in Organ Transplantation
Issue number3
StatePublished - Jun 1 2008


  • Clinical trials
  • Endpoints
  • Liver transplantation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation


Dive into the research topics of 'Endpoints in trials for clinical liver transplantation'. Together they form a unique fingerprint.

Cite this